Early vascular ageing in translation: From laboratory investigations to clinical applications in cardiovascular prevention

Journal of Hypertension

Volumn 31, Issue 8, 2013, Pages 1517-1526

  Nilsson, Peter M ^a   Boutouyrie, Pierre ^b   Cunha, Pedro ^c   Kotsis, Vasilios ^d   Narkiewicz, Krzysztof ^e   Parati, Gianfranco ^f,g   Rietzschel, Ernst ^h   Scuteri, Angelo ⁱ   Laurent, Stephane ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF MINHO   (Portugal)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF GDA SK   (Poland)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g GHENT UNIVERSITY   (Belgium)

^h IRCCS SAN RAFFAELE PISANA   (Italy)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ageing; Arterial stiffness; Blood pressure; Cognition; Hyperglycemia; Hypertension; Metabolism; Microcirculation; Risk

Indexed keywords

LINOLEIC ACID; COLLAGEN;

AGING; ARTERIAL STIFFNESS; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COGNITIVE DEFECT; CORONARY ARTERY; EARLY VASCULAR AGING; GENETICS; HEART; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; REVIEW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHEMISTRY; ELASTICITY; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK;

AGING; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COGNITION DISORDERS; COLLAGEN; ELASTICITY; HEMODYNAMICS; HUMANS; RISK; VASCULAR STIFFNESS;

EID: 84893457418     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328361e4bd     Document Type: Review

References (131)

1. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008; 7:34-42.
2. Leonard A. The theories of Thomas Sydenham (1624-1689). J R Coll Physicians Lond 1990; 24:141-143.
3. Nilsson PM. Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag 2008; 4:547-552.
4. Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome (review). J Hypertens 2008; 26:1049-1057.
5. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. (Brief Review) Hypertension 2009; 54:3-10.
6. Franklin SS. Do diabetes and hypertension interact to accelerate vascular ageing? J Hypertens 2002; 20:1693-1696.
7. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005; 46:454-462.
8. O'Rourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 2010; 15:461-468.
9. Laurent S, Briet M, Boutouyrie P. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension 2009; 54:388-392.
10. Kotsis V, Stabouli S, Karafillis I, Nilsson P. Early vascular aging and the role of central blood pressure. J Hypertens 2011; 29:1847-1853.
11. Kotsis V, Stabouli S, Karafillis I, Papakatsika S, Rizos Z, Miyakis S, et al. Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study). Atherosclerosis 2011; 219:194-199.
12. Neisius U, Bilo G, Taurino C, McClure JD, Schneider MP, Kawecka- Jaszcz K, et al. Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens 2012; 30:67-74.
13. Safar ME, Nilsson PM, Blacher J, Mimran A. Pulse pressure, arterial stiffness, and end-organ damage.Curr Hypertens Rep 2012; 14:339-344.
14. Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012; 60:369-377.
15. Thanassoulis G, Lyass A, Benjamin EJ, Larson MG, Vita JA, Levy D, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study. Circulation 2012; 125:2836-2843.
16. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308:875-881.
17. Lakatta EG. Human aging: changes in structure and function. JAmColl Cardiol 1987; 10:42A-47A.
18. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005; 45:1050-1055.
19. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
20. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension highlights. Hypertension 2007; 49:1202-1206.
21. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al., Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well functioning older adults. Circulation 2005; 111:3384- 3390.
22. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51:527-539.
23. Alonso-Fernández P, De la Fuente M. Role of the immune system in aging and longevity. Curr Aging Sci 2011; 4:78-100.
24. Scuteri A, Orru M, Morrell C, Piras MG, Taub D, Schlessinger D, et al. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 2011; 215:459-464.
25. Salvioli S, Monti D, Lanzarini C, Conte M, Pirazzini C, Bacalini MG, et al. Immune system, cell senescence, aging and longevity: Inflammaging reappraised. Curr Pharm Des 2013; 19:1675-1679.
26. Laurent S. Arterial stiffness: intermediate or surrogate endpoint for cardiovascular events? Eur Heart J 2005; 26:1152-1154.
27. Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 2009; 81:637-648.
28. Laurent S, Parati G. Heritability of arterial stiffness and central blood pressure: the Holy Grail for detecting patients at high cardiovascular risk? J Hypertens 2012; 30:1511-1513.
29. Luft FC. Molecular mechanisms of arterial stiffness: new insights. J Am Soc Hypertens 2012; 6:436-438.
30. Mulders TA, van den Bogaard B, Bakker A, Trip MD, Stroes ES, van den Born BJ, et al. Arterial stiffness is increased in families with premature coronary artery disease. Heart 2012; 98:490-494.
31. Tarasov KV, Sanna S, Scuteri A, Strait JB, Orrù M, Parsa A, et al. COL4A1 is associated with arterial stiffness by genome-wide association scan. Circ Cardiovasc Genet 2009; 2:151-158.
32. Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Yasmin, et al. Common genetic variation in the 30-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet 2012; 5:81-90.
33. International Consortium for Blood Pressure Genome-Wide Association Studies. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, . et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478:103-109.
34. Durier S, Fassot C, Laurent S, Boutouyrie P, Couetil JP, Fine E, et al. Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 2003; 108:1845-1851.
35. Galmiche G, Labat C, Mericsay M, Ait Assia K, Blanc J, Retailleau K, et al. Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice. Circ Res 2013; 112:1035-1045.
36. De Meyer T, Rietzschel ER, De Buyzere ML, Van Criekinge W, Bekaert S. Telomere length and cardiovascular aging: The means to the ends? Ageing Res Rev 2011; 10:297-303.
37. Hallows SE, Regnault TR, Betts DH. The long and short of it: the role of telomeres in fetal origins of adult disease. J Pregnancy 2012; 2012:638476; doi:10.1155/2012/638476.
38. Laurent S, Cockkroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
39. Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, et al., Nephrotest Study Group. Arterial remodeling associates with CKD progression. J Am Soc Nephrol 2011; 22:967-974.
40. Briet M, Pierre B, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 82:388-400.
41. Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostör AJ, Hall FC, Rudd JH, Wilkinson IB. Anti-Tumor Necrosis Factor-a Therapy Reduces Aortic Inflammation and Stiffness in Patients with Rheumatoid Arthritis. Circulation 2012; 126:2473-2480.
42. Zanoli L, Cannavò M, Rastelli S, Di Pino L, Monte I, Di Gangi M, et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012; 30:1775-1781.
43. Lindharsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp- Pedersen C, Hansen PR. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011; 70:929-934.
44. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012; 42:1524-1529.
45. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, et al. Inflammation, immunity and hypertension. Hypertension 2011; 57:132-140.
46. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, et al., on behalf of The NephroTest study group. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012; 60:1451-1457.
47. Briet M, Bozec E, Laurent S, Fassot C, Jacquot C, Froissart M, et al. Arterial stiffness and enlargement in mild to moderate chronic kidney disease. Kidney Int 2006; 69:350-357.
48. Sekikawa A, Shin C, Curb JD, Barinas-Mitchell E, Masaki K, El-Saed A, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis 2012; 222:473-477.
49. Verbeke F, Maréchal C, Van Laecke S, Van Biesen W, Devuyst O, Van Bortel LM, et al. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011; 58:833- 838.
50. Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, et al. Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol 2008; 19:798-805.
51. Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 2005; 36:2193-2197.
52. Scuteri A, Brancati AM, Gianni W, Assisi A, Volpe M. Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. J Hypertens 2005; 23:1211-1216.
53. Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 2007; 25:1035-1040.
54. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008; 51:99-104.
55. Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio- Mazoyer N, et al., for the PROGRESS MRI Substudy Investigators. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009; 40:2219-2221.
56. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 2008; 52:1120-1126.
57. Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40:1229-1236.
58. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, KjartanssonÓ, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility - Reykjavik study. Brain 2011; 134 (Pt11):3398-3407.
59. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al., American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American stroke association. Stroke 2011; 42:2672-2713.
60. Silventoinen K, Modig-Wennerstad K, Tynelius P, Rasmussen F. Association between intelligence and coronary heart disease mortality: a population-based cohort study of 682 361 Swedish men. Eur J Cardiovasc Prev Rehabil 2007; 14:555-560.
61. Batty GD, Deary IJ, Benzeval M, Der G., Does IQ predict cardiovascular disease mortality as strongly as established risk factors? Comparison of effect estimates using the West of Scotland Twenty-07 cohort study. Eur J Cardiovasc Prev Rehabil 2010; 17:24-27.
62. Gasecki D, Rojek A, Kwarciany M, Kowalczyk K, Boutouyrie P, Nyka W, et al. Low pulse wave velocity is associated with early neurological improvement after acute ischemic stroke. Atherosclerosis 2012; 225:348-352.
63. Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, et al. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke 2012; 43:543-544.
64. Swierblewska E, Hering D, Kara T, Kunicka K, Kruszewski P, Bieniaszewski L, et al. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens 2010; 28:979-984.
65. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodega°rd K, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 h in 8938 subjects from 11 populations. Hypertension 2010; 55:1049-1057.
66. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target organ damage. J Hypertens 1987; 5:93-98.
67. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-h blood pressure variability. J Hypertens 1993; 11:1133- 1137.
68. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39:710-714.
69. Narkiewicz K, Winnicki M, Schroeder K, Phillips BG, Kato M, Cwalina E, Somers VK. Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension 2002; 39:168-172.
70. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986; 8:147-153.
71. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension 1995; 25:1276-1286.
72. Parati G, Faini A, Valentini M. Blood pressure variability: its measurement and significance in hypertension. Curr Hypertens Rep 2006; 8:199-204.
73. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-h average blood pressure. Hypertension 1983; 5:264-269.
74. Parati G, Vrijens B, Vincze G. Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding. Am J Hypertens 2008; 21:123-125.
75. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka- Jaszcz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007; 25:2058-2066.
76. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539- 546.
77. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodega°rd K, et al., International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219-1229.
78. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007; 49:1265-1270.
79. Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23:505-511.
80. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats. Am J Hypertens 1994; 7:453-459.
81. Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, et al. Aortic distensibility and structural changes in sino-aortic denervated rats. Hypertension 1995; 26:337-340.
82. Lacolley P, Glaser E, Challande P, Boutouyrie P, Mignot JP, Duriez M, et al. Structural changes and in situ aortic pressure-diameter relationship in longterm chemical-sympathectomized rats. Am J Physiol 1995; 269:H407-H416.
83. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al., ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19:1981-1989.
84. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375:938-948.
85. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012; 30:1241-1251.
86. Bilo G, Parati G. Rate of blood pressure changes assessed by 24 h ambulatory blood pressure monitoring: another meaningful index of blood pressure variability? J Hypertens 2011; 29:1054-1058.
87. Palatini P, Casiglia E, Gasowski J, Głuszek J, Jankowski P, Narkiewicz K, et al. Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag 2011; 7:725-739.
88. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Ageand gender-related ventricular-vascular stiffening: a communitybased study. Circulation 2005; 112:2254-2262.
89. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107:714-720.
90. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. Hypertension 2010; 56:563-570.
91. Chirinos J, Segers P, Gillebert TC, Gupta AK, De Buyzere ML, De Bacquer D, et al., on behalf of the Asklepios Investigators. Arterial properties as determinants of time-varying myocardial stress in humans. Hypertension 2012; 60:64-70.
92. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
93. Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. Eur Heart J 2010; 31:2351-2358.
94. Cooney MT, Vartiainen E, Laatikainen T, De Bacquer D, McGorrian C, Dudina A, et al., on behalf of the SCORE and FINRISK investigators. Cardiovascular risk age: concepts and practicalities. Heart 2012; 98:941-946.
95. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
96. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121:505-511.
97. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
98. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39:10-15.
99. Laurent S, Alivon M, Beaussier H, Boutouyrie P. Aortic stiffness as a tissue biomarker for predicting future cardiovascular events in asymptomatic hypertensive subjects. Ann Med 2012; 44 (Suppl 1): S93-S97.
100. Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp- Pedersen C, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010; 31:883- 891.
101. Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension 2012; 60:518-522.
102. Boutouyrie P, Vermeersch S, and the Reference Values for Arterial Stiffness' Collaboration. Reference values for carotid-femoral pulse wave velocity in the reference values for arterial stiffness' collaboration database. Eur Heart J 2010; 31:2338-2350.
103. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al., Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
104. National Institute of Health. Weight loss does not lower heart disease risk from type 2 diabetes (press release). NIH News, 19th October 2012.
105. Gibbs BB, Brancati FL, Chen H, Coday M, Jakicic JM, Lewis CE, et al. Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study. Eur J Prev Cardiol 2012; [Epub ahead of print].
106. Kokkinos P, Myers J, Doumas M, Faselis C, Manolis A, Pittaras A, et al. Exercise capacity and all-cause mortality in prehypertensive men. Am J Hypertens 2009; 22:735-741.
107. Seals DR, Walker AE, Pierce GL, Lesniewski LA. Habitual exercise and vascular ageing. J Physiol 2009; 587 (Pt 23):5541-5549.
108. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012; 33:1635-1701.
109. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, Mahmud A. Pharmacological modulation of arterial stiffness. Drugs 2011; 71:1689-1701.
110. Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, et al., investigators. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a metaanalysis of individual data in 294 patients. J Hypertens 2011; 29:1034- 1042.
111. Boutouyrie P, Achouba A, Trunet P, Laurent S, EXPLOR Trialist Group. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010; 55:1314-1322.
112. Sharman JE, Marwick TH, Abhayaratna WP, Stowasser M. Rationale and design of a randomized study to determine the value of central Blood Pressure for GUIDing managEment of hypertension: the BP GUIDE study. Am Heart J 2012; 163:761-767.
113. Laurent S, Schlaich M, Esler M. New drugs, procedures, and devices for hypertension. Lancet 2012; 380:591-600.
114. Fonseca VA. Ongoing clinical trials evaluating the cardiovascular safety and efficacy of therapeutic approaches to diabetes mellitus. Am J Cardiol 2011; 108 (Suppl 3):52B-58B.
115. Sitagliptin Cardiovascular Outcome Study (0431-082 AM1) (TECOS) at www.clinicaltrial.org (NCT00790205) [Accessed August 2012].
116. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study. Am Heart J 2011; 162:818-825.
117. CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes, at www.clinicaltrial.org (NCT01243424) [Accessed April 2013].
118. Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation (LEADER1), at www.clinicaltrial.org (NCT01179048) [Accessed February 2013].
119. CANVAS - CANagliflozin cardioVascular Assessment Study, at www.clinicaltrial.org (NCT01032629) [Accessed April 2013].
120. Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA, Herman GA. Effect of sitagliptin, a dipeptidyl peptidase- 4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol 2008; 48:592-598.
121. Paisley AJ, Yadav R, Younis N, Rao-Balakrishna P, Soran H. Dapagliflozin: a review on efficacy, clinical effectiveness and safety. Expert Opin Investig Drugs 2013; 22:131-140.
122. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48:1684-1699.
123. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009; 54:1328-1336.
124. Davey Smith G, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR. Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 2005; 366:1484-1498.
125. Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ 2012; 345:e7325; doi:10.1136/bmj.e7325.
126. Melander O, Maisel AS, Almgren P, Manjer J, Belting M, Hedblad B, et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA 2012; 308:1469- 1475.
127. IL6R Genetics Consortium and Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012; 379:1205- 1213.
128. The Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012; 379:1214-1224.
129. Scuteri A, Orru M, Morrell CH, Tarasov K, Schlessinger D, Uda M, Lakatta EG. Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. Atherosclerosis 2012; 221:189-197.
130. Lemogoum D, Ngatchou W, Janssen C, Leeman M, Van Bortel L, Boutouyrie P, et al. Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies. Hypertension 2012; 60:123-128.
131. Nilsson PM. Genetic and environmental determinants of early vascular ageing (EVA). Curr Vasc Pharmacol 2012; 10:700-701.